上海医药：关于缩宫素注射液及醋酸奥曲肽注射液获得菲律宾药品注册证书的公告

Core Insights - Shanghai Pharmaceuticals announced the approval of its products, Oxytocin Injection and Acetate Octreotide Injection, by the Philippines Food and Drug Administration [2] Company Summary - The company’s subsidiary, Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd., received drug registration certificates for the aforementioned products [2] - The approved drugs are now set to be marketed in the Philippines [2]